郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

病毒感染Screening and identification of Lassa virus endonuclease-targeting inhibitors from a fragment-based drug discovery library.

期刊：Antiviral research发表年份：2022作者：Xiaohao Lan; Yueli Zhang; Xiaoying Jia; Siqi Dong; Yang Liu; Mengmeng Zhang; Jiao Guo; Junyuan Cao; Yu Guo; Gengfu Xiao; Wei Wang
阅读更多 →

病毒感染Peptidic defective interfering gene nanoparticles against Omicron, Delta SARS-CoV-2 variants and influenza A virus in vivo.

期刊：Signal transduction and targeted therapy发表年份：2022作者：Hanjun Zhao; Chuyuan Zhang; Hoiyan Lam; Xinjie Meng; Zheng Peng; Man Lung Yeung; Jasper Fuk-Woo Chan; Kelvin Kai-Wang To; Kwok-Yung Yuen
阅读更多 →

病毒感染Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron.

期刊：Cell reports发表年份：2022作者：Siling Wang; Hui Sun; Yali Zhang; Lunzhi Yuan; Yizhen Wang; Tianying Zhang; Shaojuan Wang; Jinlei Zhang; Hai Yu; Hualong Xiong; Zimin Tang; Liqin Liu; Yang Huang; Xiuting Chen; Tingting Li; Dong Ying; Chang Liu; Zihao Chen; Quan Yuan; Jun Zhang; Tong
阅读更多 →

病毒感染Induction of Th1 and Th2 in the protection against SARS-CoV-2 through mucosal delivery of an adenovirus vaccine expressing an engineered spike protein.

期刊：Vaccine发表年份：2022作者：Nai-Hsiang Chung; Ying-Chin Chen; Shiu-Ju Yang; Yu-Ching Lin; Horng-Yunn Dou; Lily Hui-Ching Wang; Ching-Len Liao; Yen-Hung Chow
阅读更多 →